BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21154658)

  • 1. A new liquid chromatography/mass spectrometry method for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine.
    Bhat SH; Gelhaus SL; Mesaros C; Vachani A; Blair IA
    Rapid Commun Mass Spectrom; 2011 Jan; 25(1):115-21. PubMed ID: 21154658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct analysis of tobacco-specific nitrosamine NNK and its metabolite NNAL in human urine by LC-MS/MS: evidence of linkage to methylated DNA lesions.
    Hu CW; Hsu YW; Chen JL; Tam LM; Chao MR
    Arch Toxicol; 2014 Feb; 88(2):291-9. PubMed ID: 24057573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High throughput liquid and gas chromatography-tandem mass spectrometry assays for tobacco-specific nitrosamine and polycyclic aromatic hydrocarbon metabolites associated with lung cancer in smokers.
    Carmella SG; Ming X; Olvera N; Brookmeyer C; Yoder A; Hecht SS
    Chem Res Toxicol; 2013 Aug; 26(8):1209-17. PubMed ID: 23837805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.
    Carmella SG; Borukhova A; Akerkar SA; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):113-20. PubMed ID: 9037562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a method for the determination of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine of nonsmokers and smokers using liquid chromatography/tandem mass spectrometry.
    Hou H; Zhang X; Tian Y; Tang G; Liu Y; Hu Q
    J Pharm Biomed Anal; 2012 Apr; 63():17-22. PubMed ID: 22366322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of an assay for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine for the assessment of tobacco-related harm.
    Lu W; Ferguson SG; Nichols DS; Patel R; Jacobson GA
    J Pharm Biomed Anal; 2016 Nov; 131():327-332. PubMed ID: 27632782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a rapid method for the simultaneous separation and determination of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and its N- and O-glucuronides in human urine by liquid chromatography-tandem mass spectrometry.
    Yao L; Zheng S; Guan Y; Yang J; Liu B; Wang W; Zhu X
    Anal Chim Acta; 2013 Jul; 788():61-7. PubMed ID: 23845482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine.
    Carmella SG; Han S; Fristad A; Yang Y; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1257-61. PubMed ID: 14652291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variability in the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL).
    Ter-Minassian M; Asomaning K; Zhao Y; Chen F; Su L; Carmella SG; Lin X; Hecht SS; Christiani DC
    Int J Cancer; 2012 Mar; 130(6):1338-46. PubMed ID: 21544809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Glucuronidation Genotypes and Urinary NNAL Metabolic Phenotypes in Smokers.
    Chen G; Luo S; Kozlovich S; Lazarus P
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1175-1184. PubMed ID: 27197298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low ratio of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol-glucuronides (NNAL-Gluc)/free NNAL increases urothelial carcinoma risk.
    Chung CJ; Lee HL; Yang HY; Lin P; Pu YS; Shiue HS; Su CT; Hsueh YM
    Sci Total Environ; 2011 Apr; 409(9):1638-42. PubMed ID: 21334728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of N-glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human liver: importance of UDP-glucuronosyltransferase 1A4.
    Wiener D; Doerge DR; Fang JL; Upadhyaya P; Lazarus P
    Drug Metab Dispos; 2004 Jan; 32(1):72-9. PubMed ID: 14709623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine samples stored at various temperatures.
    Xia Y; Bernert JT
    J Anal Toxicol; 2010 Sep; 34(7):411-5. PubMed ID: 20822679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of maternal tobacco smoking or exposure to second-hand smoke on the levels of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine of mother and the first urine of newborn.
    Florek E; Piekoszewski W; Basior A; Merritt AT; Mazela J; Lechowicz W; Kornacka MK; Kramer L
    J Physiol Pharmacol; 2011 Jun; 62(3):377-83. PubMed ID: 21893699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subpicogram per milliliter determination of the tobacco-specific carcinogen metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine using liquid chromatography-tandem mass spectrometry.
    Jacob P; Havel C; Lee DH; Yu L; Eisner MD; Benowitz NL
    Anal Chem; 2008 Nov; 80(21):8115-21. PubMed ID: 18841944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer.
    Derby KS; Cuthrell K; Caberto C; Carmella S; Murphy SE; Hecht SS; Le Marchand L
    Int J Cancer; 2009 Nov; 125(10):2418-24. PubMed ID: 19598261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation and accumulation of pyridyloxobutyl DNA adducts in F344 rats chronically treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.
    Lao Y; Yu N; Kassie F; Villalta PW; Hecht SS
    Chem Res Toxicol; 2007 Feb; 20(2):235-45. PubMed ID: 17305407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple high-throughput analytical method using ultra-performance liquid chromatography coupled with tandem mass spectrometry to quantify total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine.
    Yang JY; Ahn HK; Lee SW; Han YJ; Oh YJ; Velázquez-Armenta EY; Nava-Ocampo AA
    Clin Chem Lab Med; 2015 Jul; 53(8):1249-57. PubMed ID: 25720081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between the urine profile of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolites and N7-methylguanine in urothelial carcinoma patients.
    Lee HL; Hsueh YM; Chung CJ; Pu YS; Chang LW; Hsieh DP; Liou SH; Lin P
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3390-5. PubMed ID: 19064555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine by extraction on a molecularly imprinted polymer column and liquid chromatography/atmospheric pressure ionization tandem mass spectrometry.
    Xia Y; McGuffey JE; Bhattacharyya S; Sellergren B; Yilmaz E; Wang L; Bernert JT
    Anal Chem; 2005 Dec; 77(23):7639-45. PubMed ID: 16316171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.